Case highlights unusual presentation
Case illustrates mortality of severe disease
A better understanding and a hope for better outcomes
Second case ever reported highlights complexity, rarity
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Translational human plasma studies
Toward an evidence-based approach
Findings from a recent randomized trial investigating mepolizumab
A better outlook
What is cancer immunotherapy teaching us?
Advertisement
Advertisement